Page 8 of 10
< 1 2 3 4 5 6 7 8 9 10  >
  • Allergology

    Inhaled Steroids in Asthma

    In patients with persistent asthma, it is calculated an average lack of response in 30% of cases. In this NIH-sponsored study, researchers tried to establish whether the short-term response can, in some way, predict the response of prolonged administrations.

    MedNews - Fri, 8 June 2007
    http://mn.medsurfnews.com/

  • Oncology

    Experimental Drug Improves Survival in Advanced Kidney Cancer

    The experimental drug temsirolimus helps people with advanced kidney cancer live longer than standard treatment, a new study says.

    American Cancer Society - Thu, 7 June 2007
    http://www.cancer.org/

  • General Surgery

    Drug Therapy: Prevention and Treatment of Major Blood Loss

    The most common medical cause of major blood loss is surgery, particularly cardiovascular procedures, liver transplantation and hepatic resection, and major orthopedic procedures. Excessive blood loss may also occur for other reasons, such as trauma. This article reviews the benefits of hemostatic drugs and considers the associated risk of adverse events, particularly thrombotic complications.

    New England Journal of Medicine - Thu, 7 June 2007
    http://www.nejm.org

  • Cardiology

    New biodegradable magnesium stents for coronary arteries

    Biodegradable magnesium stents have been developed to treat blockages in coronary arteries, which can degrade within four months and achieve the same results as conventional stents

    The Lancet - Thu, 7 June 2007
    http://www.thelancet.com

  • Oncology

    Opportunities for improving the therapeutic ratio for patients with sarcoma

    At least 50 different subtypes of sarcoma exist, differentiated on the basis of histology and molecular characteristics. Jay Wunder and colleagues discuss the optimisation of conventional modalities and new technologies under development for management of sarcomas.

    The Lancet Oncology - Thu, 7 June 2007
    http://www.thelancet.com/journals/lanonc

  • Oncology

    Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data

    Previous studies have suggested microvessel density (MVD) is a prognostic factor in patients with NSCLC, but results have been hampered by methodological inconsistencies.

    The Lancet Oncology - Thu, 7 June 2007
    http://www.thelancet.com/journals/lanonc

  • Dietetics and Nutrition

    Innovative approach tackles malnutrition in the community

    An innovative approach is showing progress in addressing severe acute malnutrition, which affects an estimated 20 million children under the age of five worldwide.

    World Health Organization - Thu, 7 June 2007
    http://www.who.int

  • Infectious Diseases

    How Sneaky HIV Escapes Cells

    Like hobos on a train, HIV, the virus that causes AIDS, uses a pre-existing transport system to leave one infected cell and infect new ones.

    Johns Hopkins Hospital - Thu, 7 June 2007
    http://www.hopkinshospital.org

  • Oncology

    Less Breast Cancer Radiation Appears Safe

    Lower doses of radiation may offer women the same level of protection from breast cancer recurrence with fewer side effects, researchers say.

    American Cancer Society - Thu, 7 June 2007
    http://www.cancer.org/

  • Oncology

    Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

    Radiotherapy plus hormone suppression prevents recurrence in patients with prostate cancer, and local control might be improved by escalated doses of radiotherapy.

    The Lancet Oncology - Tue, 5 June 2007
    http://www.thelancet.com/journals/lanonc

< 1 2 3 4 5 6 7 8 9 10  >
Page 8 of 10